UT-MOST: Advancing Sepsis Care Across the UT System

Sepsis remains a leading cause of mortality and prolonged hospital stays, requiring timely recognition and treatment to improve patient outcomes. The University of Texas Managing and Optimizing Sepsis Treatment (UT-MOST) initiative, supported by UT-HIP, is a system-wide effort designed to improve sepsis care through data-driven collaboration and clinical process improvement.

Under the leadership of UT-HIP Quality Collaborative, UT-MOST brings together stakeholders from across UT-affiliated hospitals to align on best practices, share data, and drive meaningful outcomes for patients. The initiative is currently focused on three strategic aims:

  • AIM 1: Dashboard Creation and Process Improvement Leveraging both registry data and Vizient benchmarks to create actionable dashboards that highlight variation and guide local improvement efforts.
  • AIM 2: Sepsis Registry Development Establishing a shared data infrastructure across all UT sites using a common data model to standardize definitions and support benchmarking.
  • AIM 3: Time to Antibiotics Improving early identification and antibiotic administration for patients with septic shock presenting in the emergency department.

This work is being strengthened through a "Listening Tour" across UT institutions, allowing the UT-MOST team to connect directly with front-line providers, learn about site-specific challenges, and co-develop solutions.

As UT-MOST continues to grow, all UT institutions are encouraged to engage—whether through participation in working groups, contributing success stories, or helping shape future improvement priorities.

Together, we are building a sustainable, high-impact model for sepsis care improvement across Texas.

 

MD Anderson Highlights: Evidence in Action

During the latest UT-MOST session, MD Anderson shared impactful metrics and strategies showcasing their sepsis protocol:

Area

MD Anderson Data

Sepsis Committee OversightEstablished in 2024, meets monthly—100% of sepsis cases reviewed.
Electronic ScreeningED screening tools capture 95% of sepsis cases within 2 hours of triage.
Antibiotic TimingAntibiotic administration within 60 minutes achieved in 89% of cases.
Fluid Resuscitation92% of patients received guideline-compliant 30 mL/kg fluid boluses within first hour.
Bundle Compliance85% adherence to sepsis bundle components (cultures, lactate, fluids, antibiotics).
Case ReviewsMonthly root cause analyses led to two major workflow improvements in 2024.

These data points illustrate not only MD Anderson’s high standards but also the replicable strategies that can inform system-wide sepsis improvements.

As UT-MOST moves through its Listening Tour across UT hospitals, MD Anderson’s results provide a powerful benchmark—and a practical playbook—for success. All UT sites are encouraged to:

  • Join Sepsis Working Groups
  • Implement electronic ED Screening for early identification of sepsis
  • Adopt Real-Time Monitoring Tools
  • Engage in Regular Case Reviews

MD Anderson’s success—anchored by rapid screening, timely treatment, and rigorous review—demonstrates the impact of a disciplined, data-driven sepsis framework. As UT-MOST advances, we invite all UT hospitals to leverage these insights to help elevate sepsis care across Texas.